HD-tDCS as augmentation therapy in late-life depression (Cancelled)
Departmental Research Seminar
Dr. Calvin Pak Wing CHENG
Prof. Eric Yu Hai CHEN
30 January 2020
G/F, Room LG-S2, Laboratory Block, Faculty of Medicine Building
HD-tDCS has great potential as a new treatment option for depression based on its effects on neural plasticity and enhancement of serotonin and cognitive function. A previous meta-analysis suggested the effectiveness and tolerability in patients with depression, despite the conflicting results. The efficacy of HD-tDCS in patients with LLD remains unknown due to the scarcity of research.